OneDrop

High-Level Overview

One Drop is a New York-based precision health company founded in 2015 that builds a digital platform for managing chronic conditions like diabetes, prediabetes, high blood pressure, and high cholesterol.[1][2][3] It serves individuals worldwide through an AI-powered mobile app that integrates continuous glucose monitoring (CGM), blood glucose meters, insulin pumps, personalized coaching from certified health professionals, and FDA-cleared connected devices, solving the problem of reactive chronic care by enabling proactive, data-driven decisions to improve health outcomes and reduce costs.[1][2][3][4] With $154.4 million in total funding, $26 million in 2024 revenue, and over 25 billion biometric data points collected, One Drop demonstrates strong growth momentum, including a 450% revenue increase from 2017-2020 (ranking #287 on Deloitte's 2021 Technology Fast 500) and expansion post-acquisition by Transom Capital Group in early 2024.[1][3][4][6]

Origin Story

One Drop was founded in 2015 in New York City by entrepreneurs leveraging expertise in mobile technology, data science, and healthcare to address gaps in chronic disease management.[2][3][4] The idea emerged from recognizing the need for a unified platform that combines device data logging (e.g., glucose levels from meters, CGMs, and pumps) with predictive analytics and behavioral coaching, moving beyond fragmented tools to empower users with actionable insights on factors like food, insulin, and exercise.[2][4] Early traction built through rapid adoption of its app, amassing billions of data points and achieving milestones like surpassing 25 billion biometric data points by 2021, while securing $154.4 million in funding across six rounds, including a $64 million latest raise.[3][4] A pivotal moment came with its 2024 acquisition by Transom Capital Group, aligning with scaled growth strategies.[1]

Core Differentiators

• AI-Powered Predictive Platform: Combines continuous diagnostics, machine learning algorithms, and 25+ billion biometric data points for personalized insights and accurate outcomes forecasts, outperforming reactive systems.[1][2][3][4]
• Integrated Ecosystem: Supports diverse devices (CGMs, meters, pumps), one-on-one telehealth coaching, and behavior change programs in a single app, with global accessibility across the US, UK, EU, and UAE.[1][2]
• User-Centric Design and Outcomes: FDA-cleared devices, proactive monitoring, and data visualization linking lifestyle to glucose levels, driving cost savings and better health (e.g., 450% growth 2017-2020).[3][4][6]
• Proven Scale and Innovation: Award-winning solution with a mission-driven culture emphasizing agile development, post-acquisition momentum, and competition against players like Glooko, Livongo, and Omada Health.[1][2][3]

Role in the Broader Tech Landscape

One Drop rides the wave of precision health and digital therapeutics, capitalizing on AI, wearables, and big data to shift chronic care from episodic to continuous and predictive amid rising global prevalence of diabetes and comorbidities.[1][2][3] Timing aligns with post-pandemic telehealth acceleration, regulatory nods for connected devices, and payer demands for cost-effective outcomes, bolstered by its 25 billion+ data trove for superior ML models.[1][4] Market forces like aging populations, CGM adoption, and value-based care favor its model, influencing the ecosystem by setting benchmarks for integrated platforms that empower patients and providers while competing in a crowded field of diabetes managers like Glooko and Omada.[2][3]

Quick Take & Future Outlook

One Drop is poised for accelerated global expansion under Transom Capital, leveraging its data moat and AI edge to penetrate emerging markets and broaden beyond diabetes into hypertension and cholesterol management.[1][3] Trends like multimodal sensing, generative AI for coaching, and partnerships with payers/health systems will shape its path, potentially evolving influence through B2B offerings for providers. As chronic care digitizes, One Drop's proactive platform positions it to redefine accessible health empowerment, building on its foundational mission to transform lives through data-driven precision.[1][2]